BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 818607)

  • 1. The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.
    Bowen FW; Renfield M
    Pediatr Res; 1976 Apr; 10(4):213-5. PubMed ID: 818607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.
    Scott JR; Beer AE; Guy LR; Liesch M; Elbert G
    Obstet Gynecol; 1977 Jan; 49(1):9-14. PubMed ID: 401536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho (d) immune globulin (human).
    Med Lett Drugs Ther; 1974 Jan; 16(1):3-4. PubMed ID: 4202567
    [No Abstract]   [Full Text] [Related]  

  • 5. The investigation of infants with RhD-negative mothers: can we safely omit the umbilical cord blood direct antiglobulin test?
    James RM; McGuire W; Smith DP
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F301-4. PubMed ID: 20659940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
    Freda VJ; Gorman JG; Pollack W; Bowe E
    N Engl J Med; 1975 May; 292(19):1014-6. PubMed ID: 804134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of Rho(D) immune globulin (human) in Canada.
    Bryant EC; Hart GD; Cairns D; Gamarra JA; de Veber LL; Holland CG; Hutchison JL
    Can Med Assoc J; 1969 Dec; 101(12):82-3. PubMed ID: 4188450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of artificial immunization of Rh-negative persons for the production of anti-D(RhO)-antibodies].
    Uhlig R; Fischer G; Karl H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):152-60. PubMed ID: 6157620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of prophylactic administration of anti-Rh (D) immunoglobulin, based on immunofluorescent and cytochemical methods of fetal hemoglobin determination].
    Gajewska E
    Pediatr Pol; 1973 Jun; 48(6):721-6. PubMed ID: 4198490
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Rh0(D) sensitization: a cost-effective analysis.
    Lim OW; Fleisher AA; Ziel HK
    Obstet Gynecol; 1982 Apr; 59(4):477-80. PubMed ID: 6176925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans.
    Barnes RM; Duguid JK; Roberts FM; Risk JM; Johnson PM; Finn R; Hardy J; Napier JA; Clarke CA
    Clin Exp Immunol; 1987 Jan; 67(1):220-6. PubMed ID: 3113783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of anti-Rh O antibody as part of the programme in the prevention of Rh isoimmunization in Rh-negative mothers in Australia.
    Simmons RT
    Haematologia (Budap); 1972; 6(1):165-71. PubMed ID: 4112704
    [No Abstract]   [Full Text] [Related]  

  • 16. The performance of an anti D immunoprophylaxis scheme.
    Kinnock S; Liley AW
    N Z Med J; 1974 Oct; 80(526):337-43. PubMed ID: 4216865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolytic disease of the newborn due to anti-S-antibodies].
    Gligorović VN; Gligorović S; Veselinović I; Milosević M
    Bilt Hematol Transfuz; 1977; 5(1):51-7. PubMed ID: 411482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid evaluation after intrauterine transfusion.
    Mennuti MT; Branca P; Schwarz RH
    Obstet Gynecol; 1973 Dec; 42(6):823-6. PubMed ID: 4202168
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of positive direct anti-globulin test for cord blood--in administration of anti-d immunoglobulin for postpartum immunoprophylaxis.
    Nakamura Y; Sada I; Tanaka S; Nomura Y; Shinagawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):623-5. PubMed ID: 6425437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.